Defining response to anti-VEGF therapies in neovascular AMD

Amoaku, W M, Chakravarthy, U, Gale, R, Gavin, M, Ghanchi, F, Gibson, J, Harding, S, Johnston, R L +8 more·2015·Eye

DOI 10.1038/eye.2015.48

Cited by (349)

Items 101–200 of 349

The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting
Abdullah Özkaya, Cengiz Alagöz, Rüveyde Garip · 2016 · Eye
Management of neovascular age-related macular degeneration: Taiwan expert consensus
Ling Yeung, Yi‐Ting Hsieh, Chang‐Hao Yang, Lee-Jen Chen, Shih‐Jen Chen, Cheng‐Kuo Cheng, Shwu‐Jiuan Sheu, Ching‐Yao Tsai, Tsung‐Tien Wu, Wei‐Chi Wu et al. · 2021 · Journal of the Formosan Medical Association
Characteristics and Predictors of Early and Delayed Responders to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Retrospective Analysis from the ANCHOR, MARINA, HARBOR, and CATT Trials
Richard Peter Gale, Jean‐François Korobelnik, Yit Chiun Yang, Tien Yin Wong · 2016 · Ophthalmologica
Perforating scleral vessels adjacent to myopic choroidal neovascularization achieved a poor outcome after intravitreal anti-VEGF therapy
Wangjing Yao, Jiawen Xu, Xiangjun She et al. · 2022 · Frontiers in Medicine
Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article
Stefania Miotto, Nicola Zemella, Elena Gusson, Giacomo Panozzo, Sandro Saviano, Giuseppe Scarpa, Giorgio Boschi, Stefano Piermarocchi, on behalf of the Italian GAT (Gruppo Angiografico Triveneto) Study Group · 2017 · Journal of Ocular Pharmacology and Therapeutics
Retinal Thickness Analysis Using Optical Coherence Tomography: Diagnostic and Monitoring Applications in Retinal Diseases
Seong Joon Ahn · 2025 · Diagnostics
Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up
Yan Lu, Wenzhi Huang, Yuehong Zhang, Xiongfei Huang, Xu Zhang, Haizhi Ma, Guoliang Ren, Feng Shi, Li-hui Kuang, Shigang Yan et al. · 2021 · Frontiers in Medicine
Rescue photodynamic therapy for age-related macular degeneration refractory to anti-vascular endothelial growth factor monotherapy
Miyo Yoshida, Akio Oishi, Masahiro Miyake, Sotaro Ooto, Hiroshi Tamura, Manabu Miyata, Ayako Takahashi, Masayuki Hata, Kenji Yamashiro, Akitaka Tsujikawa · 2022 · Photodiagnosis and Photodynamic Therapy
Prediction of the short-term efficacy of anti-VEGF therapy for neovascular age-related macular degeneration using optical coherence tomography angiography
Huixun Jia, Bing Lu, Zhi Yun Zhao, Yu Yang, Fenghua Wang, Minwen Zhou, Xiaodong Sun · 2022 · Eye and Vision
Bevacizumab dosing every 2 weeks for neovascular age-related macular degeneration refractory to monthly dosing
Michael Mimouni, Amit Meshi, Igor Vainer, Assaf Gershoni, Tal Koren, Noa Geffen, Arie Y. Nemet, Ori Segal · 2018 · Japanese Journal of Ophthalmology
Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study
Katie Banister, Jonathan Alistair Cook, Graham Scotland, Augusto Azuara‐Blanco, Beatriz Goulão, Heinrich Heimann, Rodolfo A. Hernández, Ruth Esther Hogg, Charlotte Kennedy, Sobha Sivaprasad et al. · 2022 · Health Technology Assessment
AMD Genomics: Non-Coding RNAs as Biomarkers and Therapeutic Targets
Charles Zhang, Leah A. Owen, John H. Lillvis, Sarah Xin Zhang, Ivana K. Kim, Margaret M. DeAngelis · 2022 · Journal of Clinical Medicine
Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series
Geraldine R. Slean, Kornwipa Hemarat, Rahul N. Khurana, Jay M. Stewart · 2016 · International Journal of Retina and Vitreous
Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration
Enrico Borrelli, Claudio Foti, Lorena Ulla, Annamaria Porreca, Ugo Introini, Maria Oliva Grassi, Pasquale Viggiano, Mario Peronetti, Rebecca Toscani, Giacomo Boscia et al. · 2025 · British Journal of Ophthalmology
Predicting response to anti-VEGF therapy in neovascular age-related macular degeneration using random forest and SHAP algorithms
Peng Zhang, Jialiang Duan, Caixia Wang · 2025 · Photodiagnosis and Photodynamic Therapy
Antibody blockade of Jagged1 attenuates choroidal neovascularization
Torleif Tollefsrud Gjølberg, Jonas Aakre Wik, Hanna Johannessen, Stig Krüger, Nicola Bassi, PANAGIOTIS F. CHRISTOPOULOS, Malin Bern, Stian Foss, Goran Petrovski, Morten C. Moe et al. · 2023 · Nature Communications
Anti-VEGF therapy resistance in neovascular age-related macular degeneration
Maria V. Budzinskaya, A A Plyukhova, P.A. Sorokin · 2017 · Russian Annals of Ophthalmology
SUSPENDING TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CASES OF FUTILITY
David T. Wong, George N. Lambrou, Anat Loewenstein, Ian Pearce, Annabelle Ayame Okada · 2019 · Retina
Complement Inhibition for Geographic Atrophy: A Tempting Target with Mixed Results
Jonathan B. Lin, Omar Alaa Halawa, Joan W. Miller, Demetrios G. Vavvas · 2021 · Journal of Clinical Medicine
Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD
Dorota Wyględowska‐Promieńska, Anna Piotrowska-Gwóźdź, Agnieszka Piotrowska-Seweryn, Grażyna Mazur-Piotrowska · 2015 · Medical Science Monitor
The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular Degeneration
I-Chia Liang, Wen‐Chin Ko, Yu-Jou Hsu, Yi-Ru Lin, Yun‐Hsiang Chang, Xv-Hui Zong, Pei-Chen Lai, Der‐Chen Chang, Chi‐Feng Hung · 2021 · International Journal of Molecular Sciences
Patterns of treatment discontinuation in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Narendra Dhingra, Deepa Upasani, Faruque D. Ghanchi · 2022 · Indian Journal of Ophthalmology
Gene Expression Within a Human Choroidal Neovascular Membrane Using Spatial Transcriptomics
Andrew P. Voigt, Nathaniel K. Mullin, E Navratil, Miles J. Flamme‐Wiese, Li‐Chun Lin, Todd E. Scheetz, Ian C. Han, Edwin M. Stone, Budd A. Tucker, Robert F. Mullins · 2023 · Investigative Ophthalmology & Visual Science
1,8-Dihydroxy-3-methoxy-anthraquinone inhibits tumor angiogenesis through HIF-1α downregulation
Su Jung Hwang, Seung Hye Cho, Hye Jung Bang, Joo-Hyun Hong, Ki Hyun Kim, HJ Lee · 2023 · Biochemical Pharmacology
Short-term outcomes of intravitreal faricimab for refractory neovascular age-related macular degeneration
Wissam Aljundi, Cristian Munteanu, Berthold Seitz, Alaa Din Abdin · 2024 · Graefe s Archive for Clinical and Experimental Ophthalmology
One-year outcome of intravitreal ziv-aflibercept therapy for non-responsive neovascular age-related macular degeneration
Imoro Zeba Braimah, Komal Agarwal, Ahmad M. Mansour, Jay Kumar Chhablani · 2017 · British Journal of Ophthalmology
miR-106b suppresses pathological retinal angiogenesis
Catherine Ménard, Ariel Molly Wilson, Agnieszka Dejda, Khalil Miloudi, François Binet, Sergio Crespo‐Garcia, Célia Parinot, Frédérique Pilon, Rachel Juneau, Elisabeth M. M. A. Andriessen et al. · 2020 · Aging
Aflibercept more effectively weans patients with neovascular age-related macular degeneration off therapy compared with bevacizumab
Xuan Cao, Jaron Castillo Sanchez, Tapan P. Patel, Zhiyong Yang, Chuanyu Guo, Danyal Malik, Anuoluwapo Sopeyin, Silvia Montaner, Akrit Sodhi · 2022 · Journal of Clinical Investigation
Pre-Existing RPE Atrophy and Defects in the External Limiting Membrane Predict Early Poor Visual Response to Ranibizumab in Neovascular Age-Related Macular Degeneration
Souska Zandi, Florian Weisskopf, Justus Gerhard Garweg, Isabel B. Pfister, Christian F. Prünte, Florian Sutter, Katja B. Hatz · 2017 · Ophthalmic surgery, lasers & imaging retina
Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular Degeneration
Jason Hsu, SAMIR N. PATEL, Jeremy D. Wolfe, Chirag P. Shah, Eric Chen, Thomas L. Jenkins, Turner D. Wibbelsman, Anthony Obeid, Mikel Mikhail, Sunir J. Garg et al. · 2020 · JAMA Ophthalmology
Genetic Variants of Complement Factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and Response to Intravitreal Anti-VEGF Treatment in Patients with Exudative Age-Related Macular Degeneration
Agnieszka Kubicka‐Trząska, Katarzyna Żuber-Łaskawiec, Sylwia Dziedzina, Marek Sanak, Bożena Romanowska‐Dixon, Izabella Karska‐Basta · 2022 · Medicina
High frequency SD-OCT follow-up leading to up to biweekly intravitreal ranibizumab treatment in neovascular age-related macular degeneration
Cengiz Türksever, Christian F. Prünte, Katja B. Hatz · 2021 · Scientific Reports
Novel Possible Protein Targets in Neovascular Age-Related Macular Degeneration: A Pilot Study Experiment
Bruno Nobre Lins Coronado, Felipe Bruno Santos da Cunha, Raphaela Menezes de Oliveira, Otávio de Tolêdo Nóbrega, Carlos André Ornelas Ricart, Wagner Fontes, Marcelo Valle de Sousa, Marcos Pereira de Ávila, Aline Maria Araújo Martins · 2022 · Frontiers in Medicine
Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
Yinchen Shen, Hanying Wang, Xiaoyin Xu · 2022 · Frontiers in Pharmacology
Visual and Anatomic Responses in Patients With Neovascular Age-Related Macular Degeneration and a Suboptimal Response to Anti-VEGF Therapy Switched to Faricimab
Ali Khodor, Stephanie K. Y. Choi, Tavish Nanda, Jonathan Thomas Caranfa, Raul E. Ruiz‐Lozano, Shilpa H. Desai, Michelle C. Liang, Caroline R. Baumal, David C. Reed, Tina Scheufele Cleary et al. · 2024 · Journal of VitreoRetinal Diseases
AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE–RELATED MACULAR DEGENERATION
Rocío Blanco-Garavito, Camille Jung, Joël Uzzan · 2017 · Retina
Complement proteins and complement regulatory proteins are associated with age-related macular degeneration stage and treatment response
Alexander Kai Thomsen, Maria Abildgaard Steffensen, Jenni Martinez Villarruel Hinnerskov, Amalie Thomsen Nielsen, Henrik Vorum, Bent Honoré, Mogens Holst Nissen, Torben Lykke Sørensen · 2024 · Journal of Neuroinflammation
RESOLUTION OF TREATMENT-RESISTANT SUBRETINAL FLUID IN A PATIENT WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION FOLLOWING ENDOPHTHALMITIS
Peter M. Kally, Yossi Sidikaro, Colin A. McCannel · 2016 · Retinal Cases & Brief Reports
Dabigatran and Wet AMD, Results From Retinal Pigment Epithelial Cell Monolayers, the Mouse Model of Choroidal Neovascularization, and Patients From the Medicare Data Base
Tanjina Akter, Balasubramaniam Annamalai, Elisabeth Obert, Kit N. Simpson, Bärbel Rohrer · 2022 · Frontiers in Immunology
The role of NAD+ metabolism in macrophages in age-related macular degeneration
Ruoyi Lin, Jing Yu · 2022 · Mechanisms of Ageing and Development
Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues
Focke Ziemssen, Bianka Sobolewska, Heidrun L. Deissler, Helmut Deißler · 2015 · Expert Opinion on Drug Safety
Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report
Xiao-Xiao Feng, Cheng Li, Wanwen Shao · 2018 · International Journal of Ophthalmology
Benefits of aflibercept treatment for age-related macular degeneration patients with good best-corrected visual acuity at baseline
Sakiko Minami, Norihiro Nagai, Misa Suzuki, Toshihide Kurihara, Hideki Sonobe, Mamoru Kamoshita, Atsuro Uchida, Hajime Shinoda, Hitoshi Takagi, Shozo Sonoda et al. · 2018 · Scientific Reports
Complement family member CFI polymorphisms and AMD susceptibility from a comprehensive analysis
Qianqian Yu, Jing Zhu, Yong Yao, Chao Sun · 2020 · Bioscience Reports
Persistence of Retinal Fluid after Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration
Dominic Wei Ting Yap, Benjamin Kye Jyn Tan, Kelvin Yi Chong Teo, Tien Yin Wong, Chui Ming Gemmy Cheung · 2025 · Ophthalmology Retina
Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration
Dinah Zur, Robyn H. Guymer, Jean‐François Korobelnik, Lihteh Wu, Francesco Viola, Nicole Eter, Stéphanie Baillif, Youxin Chen, Jennifer Arnold · 2024 · British Journal of Ophthalmology
Comparative efficacy of aflibercept and ranibizumab in the treatment of age-related macular degeneration with retinal pigment epithelial detachment: a systematic review and network meta-analysis
Zuhua Sun, Yating Yang, Bing Lin, Ying Huang, Rong Zhou, Chun Yang, Yingzi Li, Shenghai Huang, Xiaoling Liu · 2023 · BMC Ophthalmology
Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
Vasileios Efstathios Konidaris, Konstantinos T. Tsaousis, Rossella Anzidei · 2018 · Ophthalmology and Therapy
Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic
Jan Němčanský, Alexandr Stěpanov, Michal Koubek, Miroslav Veith, Yun Min Klimešová, Jan Studnička · 2019 · Journal of Ophthalmology
The role of posterior vitreous detachment on the efficacy of anti-vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration
Meira Neudorfer, Audelia Eshel Fuhrer, Dinah Zur · 2018 · Indian Journal of Ophthalmology
Intraocular neutralizing antibodies against aflibercept in patients with age related macular degeneration
Gyenes, Andrea, István, Lilla, Benyó, Fruzsina, Papp, András, Resch, Miklós, Sándor, Noémi, Józsi, Mihály, Nagy, Zoltán Z., Kovács, Illés, Kiss, Szilárd · 2023 · BMC Ophthalmology
Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab
Mathew W. MacCumber, Charles C. Wykoff, Hélène Karcher, Eser Adiguzel, Samriddhi Buxy Sinha, Saloni Vishwakarma, Andrew LaPrise, Franklin Igwe, Rita L. Freitas, Michael S. Ip et al. · 2023 · Ophthalmology
Improved functional and morphological outcomes with faricimab in nAMD eyes with poor response to prior intravitreal anti-VEGF therapy
Nathalie Bleidißel, Matthias Weichenberger, Mathias M. Maier, Nina Spielberg, Nikolaus Feucht · 2025 · International Ophthalmology
Microperimetry and Structural Risk Factors on OCT in Intermediate Age-Related Macular Degeneration
Alexander Kai Thomsen, Liselotte Fribo Gøttsche, Jenni Martinez Villarruel Hinnerskov, Mads Krüger Falk, Torben Lykke Sørensen · 2024 · Ophthalmology Retina
Glaucine inhibits hypoxia-induced angiogenesis and attenuates LPS-induced inflammation in human retinal pigment epithelial ARPE-19 cells
Ting-En Chen, Jung Lo, Shu‐Pin Huang, Kun‐Che Chang, Po‐Len Liu, Hsin‐En Wu, Yuan-Ru Chen, Yo‐Chen Chang, Ching‐Chih Liu, Po‐Yen Lee et al. · 2024 · European Journal of Pharmacology
Prise en charge individualisée des patients atteints de DMLA exsudative, le protocole IOI : injection–observation–individualisation
Oudy Semoun, Salomon Yves Cohen, Mayer Srour, Catherine P Creuzot-Garcher, Hassiba Oubraham-Mebroukine, Laurent Kodjikian, François Devin, Eric H. Souied · 2017 · Journal Français d Ophtalmologie
Long‐term results of rescue photodynamic therapy for type 1 neovascularization refractory to anti‐vascular endothelial growth factor
Un Chul Park, Bo Hee Kim, Hye Rim Choe, Dong Yun Yeon, Hyeong Gon Yu · 2020 · Acta Ophthalmologica
Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3
Shruti Chandra, Sarega Gurudas, Ian Pearce, Martin McKibbin, Ajay Kumar Kotagiri, Geeta Menon, Ben Burton, James Stephen Talks, Anna Grabowska, Faruque D. Ghanchi et al. · 2023 · Eye
Subfoveal choroidal thickness as a potential predictor of treatment response after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy
M. Jiménez-Santos, Federico Saenz-Frances, Cristina Calvo-González · 2021 · Canadian Journal of Ophthalmology
Difference Between the Incidence of Retinal Fluid Subtypes and Their Association with Visual Outcomes According to the Types of Macular Neovascularization in a Korean Population
Jae Hui Kim, Jong Woo Kim, Chul Gu Kim · 2022 · Journal of Ocular Pharmacology and Therapeutics
How Was Your Sleep? New Implications for Obstructive Sleep Apnea in Retinal Disease
Frank L. Brodie · 2016 · Retina
Intraretinal, sub-retinal, and sub-retinal pigmented epithelium fluid in non-exudative age-related macular degeneration: follow-up with OCT imaging
Anindya Samanta, Mahima Jhingan, Supriya Arora · 2021 · European Journal of Ophthalmology
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration
Parmeggiani, Francesco, Gallenga, Carla Enrica, Costagliola, Ciro, Semeraro, Francesco, Romano, Mario R., Dell’Omo, Roberto, Russo, Andrea, De Nadai, Katia, Gemmati, Donato, D’Angelo, Sergio et al. · 2019 · Scientific Reports
Interleukin-8 Promoter Polymorphism −251 A/T and Treatment Response in Neovascular Age-related Macular Degeneration
Alexander Kai Thomsen, Marie Krogh Nielsen, Charlotte Liisborg, Torben Lykke Sørensen · 2024 · Clinical ophthalmology
MicroRNA expression profiling in tears and blood as predictive biomarkers for anti-VEGF treatment response in wet age-related macular degeneration
Chu‐Yu Yen, Chi-Ming Chiu, I‐Mo Fang · 2024 · Graefe s Archive for Clinical and Experimental Ophthalmology
Outcomes After Switching to Faricimab for Refractive Macular Edema in Treatment-Experienced Eyes with Neovascular Age-Related Macular Degeneration
Yaqoob Qaseem, Kirk Kohwa Hou, Moritz S. Pettenkofer · 2024 · Clinical ophthalmology
Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
Jan Niklas Lüke, Hamdi Alquoqa, Ahmad Alsamman, Bayan Aljabary, Friederike Schaub, Ludwig Maximilian Heindl · 2022 · International Ophthalmology
Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration
Francesco Parmeggiani, Ciro Costagliola, Francesco Semeraro, Mario Rosario Romano, Michele Rinaldi, Carla Enrica Gallenga, Maria Luisa Serino, Carlo Incorvaia, Sergio D’Angelo, Katia De Nadai et al. · 2015 · International Journal of Molecular Sciences
Photodynamic therapy in VEGF inhibition non-responders—Pharmacogenetic study in age-related macular degeneration assessed with swept-source optical coherence tomography
Slawomir Jan Teper, Anna Nowińska, Jarosław Piłat, Edward Wylęgała · 2016 · Photodiagnosis and Photodynamic Therapy
Treatment failure in neovascular age-related macular degeneration is associated with a complex chemokine receptor profile
Thomas Bjerregaard, Marie Krogh Nielsen, Christopher Rue Molbech, Yousif Subhi, Torben Lykke Sørensen · 2019 · BMJ Open Ophthalmology
Optical coherence tomography angiography markers associated with treatment response in neovascular age-related macular degeneration
Ece Özdemir Zeydanlı, Gökhan Gürelik · 2020 · European Journal of Ophthalmology
Changing Vision: A Review of Pharmacogenetic Studies for Treatment Response in Age-Related Macular Degeneration Patients
Janan Arslan, Paul Nigel Baird · 2018 · Pharmacogenomics
CFH (rs1061170, rs1410996), KDR (rs2071559, rs1870377) and KDR and CFH Serum Levels in AMD Development and Treatment Efficacy
Džastina Čebatorienė, Alvita Vilkevičiūtė, Greta Gedvilaitė, Akvile Bruzaite, Loresa Kriaučiūnienė, Dalia Žaliūnienė, Rasa Liutkevičienė · 2024 · Biomedicines
From Pathophysiology to Innovative Therapies in Eye Diseases: A Brief Overview
Karolina Kłodnicka, Jacek Januszewski, Hanna J. Tyc, Anna Michalska, Alicja Forma, Barbara Teresińska, Robert Ręjdak, Jacek Baj, Joanna Dolar-Szczasny · 2025 · International Journal of Molecular Sciences
How to Judge Failure
Geoffrey Broadhead, Long T Phan, Tiarnán D L Keenan · 2025 · Ophthalmology Retina
Initial treatment response can predict one‐year treatment outcomes in neovascular age‐related macular degeneration treated according to the observe‐and‐plan regimen
Alexander Kai Thomsen, Sohaib Fasih‐Ahmad, Srinivas Reddy Sadda, Torben Lykke Sørensen · 2024 · Acta Ophthalmologica
Efficacy and prognostic factors of anti-VEGF treatment for neovascular age-related macular degeneration: An OCTA imaging-based deep learning analysis
Shengnan Liu, Yuanyuan Liu, Xiaohan Wu, Haochen Wang, Ziqi Jin, Peiru Wang, Jinyu Feng, Song Chen, Wei Zhou · 2025 · Photodiagnosis and Photodynamic Therapy
Safety of intravitreal ziv-aflibercept in choroido-retinal vascular diseases: A randomised double-blind intervention study
Imoro Zeba Braimah, Ernest Kenu, Kwesi Nyan Amissah-Arthur · 2019 · PLoS ONE
Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study
Anthony Gigon, Antonio Iskandar, Chiara Maria Eandi, Irmela Mantel · 2022 · International Journal of Retina and Vitreous
Impact of Delayed Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapy Due to the Coronavirus Disease Pandemic on the Prognosis of Patients with Neovascular Age-Related Macular Degeneration
Jae Gon Kim, Yu Cheol Kim, Kyung Tae Kang · 2022 · Journal of Clinical Medicine
Impact of anti-VEGF therapy on distinctive retina layers in patients with macular edema secondary to branch retinal vein occlusion
Hui Wang, Chanjuan Wang, Shaochi Zhang · 2023 · BMC Ophthalmology
HTRA1 rs11200638 variant and AMD risk from a comprehensive analysis about 15,316 subjects
Ying Liu, Huipeng Jin, Dong Wei, Wenxiu Li · 2020 · BMC Medical Genetics
Anti-VEGF therapy for neovascular age-related macular degeneration: causes of incomplete response
O. V. Zaytseva, N. V. Neroeva, Tatiana D. Okhotsimskaya, Бобыкин Евгений Валерьевич · 2021 · Russian Annals of Ophthalmology
Anti‐vascular endothelial growth factors treatment of wet age‐related macular degeneration: from neurophysiology to cost‐effectiveness
Pasi Vottonen · 2018 · Acta Ophthalmologica
Multimodal imaging based biomarkers predictive of early and late response to anti-VEGFs during the first year of treatment for neovascular age-related macular degeneration
Hatice Nur Tarakçıoğlu, Abdullah Özkaya, Burcu Kemer Atik, Muhittin Taşkapılı · 2018 · Journal Français d Ophtalmologie
MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Stefan Palkovits, Gerald Seidel, Laura Pertl et al. · 2017 · Retina
Chemokine System Changes Drive Age-Related Macular Degeneration and Influence Treatment Outcomes
Alexander Kai Thomsen, Maria Abildgaard Steffensen, Amalie Thomsen Nielsen, Henrik Vorum, Bent Honoré, Mogens Holst Nissen, Torben Lykke Sørensen · 2025 · Investigative Ophthalmology & Visual Science
Rare CIDEC coding variants enriched in age-related macular degeneration patients with small low-luminance deficit cause lipid droplet and fat storage defects
Sehyun Kim, Amy Stockwell, Han Qin, Simon S. Gao, Meredith S. Sagolla, Ivaylo Stoilov, Arthur Wüster, Phillip Lai, Brian L. Yaspan, Marion Jeanne · 2023 · PLoS ONE
Management of Neovascular Age-Related Macular Degeneration Treatment in France from 2008–2018: The Nationwide LANDSCAPE Study
Catherine P Creuzot-Garcher, Mayer Srour, Florian Baudin, Corinne Dot, Sylvia Nghiem‐Buffet, Jean‐François Girmens, Cédric Collin, Anne Ponthieux, Cécile Delcourt · 2023 · Ophthalmology and Therapy
Real-World Use of Off-Label MVASI in the Treatment of Patients With Neovascular AMD and DME
Marco Lombardo, Filippo Missiroli, Luca Cerri, Roberto Pietro Sorge, Massimo Cesareo, Federico Ricci · 2024 · Translational Vision Science & Technology
Artificial intelligence techniques in inherited retinal diseases: a review
Han Trinh, Jordan Vice, Zahra Tajbakhsh, Jason Charng, Khyber Alam, Fred Kuanfu Chen, Ajmal Saeed Mian · 2025 · Biomedical Physics & Engineering Express
The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic Patients
Eugene Yu‐Chuan Kang, Tzu‐Yi Lin, Sunir J. Garg et al. · 2023 · Journal of Personalized Medicine
Structural and clinical changes in previously treated type 1 macular neovascularization in non-responder AMD eyes switched to brolucizumab
Alfredo Pece, Federica Fossataro, Giulio Maione · 2023 · European Journal of Ophthalmology
Impact of umbelliprenin-containing niosome nanoparticles on VEGF-A and CTGF genes expression in retinal pigment epithelium cells
Farzad Dastaviz, Teymoor Khosravi, Ayyoob Khosravi · 2023 · International Journal of Ophthalmology
The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden – data from the Swedish Macula Register
Isac Wickman, Monica Lövestam‐Adrian, Elisabet Granstam, Ulrika Kjellström, Marion Silvia Schroeder · 2024 · BMC Ophthalmology
Impact of treat and extend criteria on proportions that can be extended after loading phase of 2 mg aflibercept therapy for neovascular age related macular degeneration: PRECISE Report 5
Sridevi Thottarath, Sarega Gurudas, Swati Chandak, Praveen J. Patel, Ajay Kumar Kotagiri, Ian Pearce, Martin McKibbin, Geeta Menon, Ben Burton, James Stephen Talks et al. · 2024 · Eye
The matricellular protein CCN5 prevents anti-VEGF drug-induced epithelial-mesenchymal transition of retinal pigment epithelium
Sora Im, Min Ho Song, Muthukumar Elangovan · 2024 · Scientific Reports
Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
In Hwan Hong, Sung Pyo Park · 2017 · Indian Journal of Ophthalmology
SARI prevents ocular angiogenesis and inflammation in mice
Wenqiu Zhang, Lei Dai, Xun Li · 2020 · Journal of Cellular and Molecular Medicine
Baseline characteristics and treatment response predictive of nAMD outcomes with ranibizumab therapy in treatment-naive patients: the RACER subgroup analysis
Ching‐Yao Tsai, Chien-Liang Wu, Cheng‐Kuo Cheng · 2023 · BMC Ophthalmology